Ferguson Wellman Capital Management, Inc Viatris Inc Transaction History

Ferguson Wellman Capital Management, Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 14, 2022	SELL	$9.95 - $12.27 $99,699 - $122,945	-10,020 Closed	0 $0
Q1 2022 Apr 14, 2022	BUY	$9.81 - $15.4 $98,296 - $154,308	10,020 New	10,020 $109,000
Q3 2021 Oct 22, 2021	SELL	$13.25 - $15.13 $139,880 - $159,727	-10,557 Closed	0 $0
Q2 2021 Jul 12, 2021	SELL	$12.97 - $16.15 $12,101 - $15,067	-933 Reduced 8.12%	10,557 $151,000
Q1 2021 Apr 26, 2021	SELL	$13.59 - $18.54 $16,022 - $21,858	-1,179 Reduced 9.31%	11,490 $161,000
Q4 2020 Feb 04, 2021	BUY	$14.3 - $18.74 $181,166 - $237,417	12,669 New	12,669 $237,000

1,102

934M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15.8B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Ferguson Wellman Capital Management, Inc, based on Form 13F filings with the SEC.

Stay updated on Ferguson Wellman Capital Management, Inc with notifications on news.